These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6408756)

  • 1. Inhibitory effect of ristocetin and factor VIII/von Willebrand factor protein on human platelet adenylate cyclase activity.
    Kao KJ; Tsai BS; McKee PA; Lefkowitz RJ; Pizzo SV
    Thromb Res; 1983 May; 30(3):301-8. PubMed ID: 6408756
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor: characterization of interaction among von Willebrand factor, ristocetin and platelet.
    Hashimoto S; Suzuki K
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):851-63. PubMed ID: 317771
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of vancomycin on ristocetin and bovine PAF-induced agglutination of human platelets.
    Baugh RF; Jacoby C; Brown JE; Hougie C
    Thromb Res; 1978 Mar; 12(3):511-21. PubMed ID: 306689
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet factor 4 does not promote von Willebrand factor binding to human platelets.
    Levine SP; Moake JL
    Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Support of ristocetin-induced platelet aggregation by procoagulant-inactive and plasmin-cleaved forms of human factor VIII/von Willebrand factor.
    Andersen JC; Switzer ME; McKee PA
    Blood; 1980 Jan; 55(1):101-8. PubMed ID: 6444272
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective binding of the factor VIII/von Willebrand factor protein to human platelets.
    Morisato DK; Gralnick HR
    Blood; 1980 Jan; 55(1):9-15. PubMed ID: 6965350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.
    Kao KJ; Pizzo SV; McKee PA
    J Clin Invest; 1979 Apr; 63(4):656-64. PubMed ID: 108291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H; Shibata A
    Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Participation of von Willebrand factor in blood platelet functions].
    Mikami S; Takahashi Y; Nishino M; Fukui H
    Nihon Rinsho; 1978 Dec; 36(12):3824-9. PubMed ID: 372620
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.
    Fass DN; Brockway WJ; Owen CA; Bowie EJ
    Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelets, von Willebrand factor, and prostaglandin I2.
    Moake JL; Tang SS; Olson JD; Troll JH; Cimo PL; Davies PJ
    Am J Physiol; 1981 Jul; 241(1):H54-9. PubMed ID: 6787937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actions of ristocetin on platelets.
    Koutts J; Stott L; Firkin BG
    Am J Hematol; 1976; 1(3):313-7. PubMed ID: 1087117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of inhibition by trinitrophenylation of the ristocetin cofactor activity of von Willebrand factor.
    Santoro SA; Cowan JF
    Biochim Biophys Acta; 1984 Feb; 797(2):178-85. PubMed ID: 6607747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-binding of the von Willebrand factor.
    Green D; Muller HP
    Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].
    Caduff T; Straub PW
    Schweiz Med Wochenschr; 1979 Mar; 109(11):399-402. PubMed ID: 34214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.